Novo Holdings A/S 13D and 13G filings for Galera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-28 4:19 pm Sale |
2023-06-27 | 13G | Galera Therapeutics, Inc. GRTX |
Novo Holdings A/S | 2,100,000 4.900% |
-359,021 (-14.60%) |
Filing |
| 2022-02-02 4:55 pm Sale |
2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Novo Holdings A/S | 2,459,021 9.300% |
-500,000 (-16.90%) |
Filing |
| 2021-02-08 4:58 pm Sale |
2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Novo Holdings A/S | 2,959,021 11.900% |
-450,000 (-13.20%) |
Filing |